These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17123443)

  • 1. Bruxism secondary to brain injury treated with botulinum toxin-A: a case report.
    El Maaytah M; Jerjes W; Upile T; Swinson B; Hopper C; Ayliffe P
    Head Face Med; 2006 Nov; 2():41. PubMed ID: 17123443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of severe bruxism with botulinum toxin type A].
    Alonso-Navarro H; Jiménez-Jiménez FJ; Plaza-Nieto JF; Pilo-De la Fuente B; Navacerrada F; Arroyo-Solera M; Calleja M
    Rev Neurol; 2011 Jul; 53(2):73-6. PubMed ID: 21720976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin injection for bruxism associated with brain injury: case report.
    Kesikburun S; Alaca R; Aras B; Tuğcu I; Tan AK
    J Rehabil Res Dev; 2014; 51(4):661-4. PubMed ID: 25144179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bruxism after brain injury: successful treatment with botulinum toxin-A.
    Ivanhoe CB; Lai JM; Francisco GE
    Arch Phys Med Rehabil; 1997 Nov; 78(11):1272-3. PubMed ID: 9365360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of masseter hypertrophy with botulinum toxin type A.
    Al-Ahmad HT; Al-Qudah MA
    Saudi Med J; 2006 Mar; 27(3):397-400. PubMed ID: 16532107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trismus after stroke/TBI: botulinum toxin benefit and use pre-PEG placement.
    Restivo DA; Maimone D; Patti F; Marchese-Ragona R; Marino G; Pavone A
    Neurology; 2005 Jun; 64(12):2152-3. PubMed ID: 15985596
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of botulinum toxin for the treatment of temporomandibular disorder.
    Freund B; Schwartz M
    Oral Health; 1998 Feb; 88(2):32-7. PubMed ID: 9610334
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of a tardive dyskinesia patient with temporomandibular disorder: a case report.
    Pekkan G; Kilicoglu A; Algin DI
    J Orofac Pain; 2010; 24(2):212-6. PubMed ID: 20401360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin as an alternative for the treatment of aesthetic deformities.
    Barbosa MV; Nahas FX; Ferreira LM; Al-Ahmad HT; Al-Qudah M
    Saudi Med J; 2006 Oct; 27(10):1613; author reply 1613. PubMed ID: 17013500
    [No Abstract]   [Full Text] [Related]  

  • 10. [Botulinum toxin type A treatment of cosmetically disturbing masseteric hypertrophy].
    Rijsdijk BA; van ES RJ; Zonneveld FW; Steenks MH; Koole R
    Ned Tijdschr Geneeskd; 1998 Mar; 142(10):529-32. PubMed ID: 9623101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The medical management of masseteric hypertrophy with botulinum toxin.
    Finn S; Ryan P; Sleeman D
    J Ir Dent Assoc; 2000; 46(3):84-6. PubMed ID: 11323940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between intramuscular and perimuscular injections of botulinum toxin type A.
    Campos JH; Oliveira LB; Queiroz TO; Santos KP; Freitas FM
    Aesthetic Plast Surg; 2006; 30(6):700-3; discussion 704. PubMed ID: 16977369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower facial contouring with botulinum toxin type A.
    Tartaro G; Rauso R; Santagata M; Santillo V; Itro A
    J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe post-traumatic bruxism with botulinum toxin-A: case report.
    Pidcock FS; Wise JM; Christensen JR
    J Oral Maxillofac Surg; 2002 Jan; 60(1):115-7. PubMed ID: 11757023
    [No Abstract]   [Full Text] [Related]  

  • 15. Botulinum toxin for the treatment of congenital entropion.
    Christiansen G; Mohney BG; Baratz KH; Bradley EA
    Am J Ophthalmol; 2004 Jul; 138(1):153-5. PubMed ID: 15234303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin for radiation-induced facial pain and trismus.
    Hartl DM; Cohen M; Juliéron M; Marandas P; Janot F; Bourhis J
    Otolaryngol Head Neck Surg; 2008 Apr; 138(4):459-463. PubMed ID: 18359354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
    Ihde SK; Konstantinovic VS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin A for treating muscular contractures in cephalic tetanus.
    García-García A; Gándara-Rey JM; Crespo-Abelleira A; Jorge-Barreiro J
    Br J Oral Maxillofac Surg; 2007 Oct; 45(7):573-5. PubMed ID: 17023100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury.
    Hori S; Patki P; Attar KH; Ismail S; Vasconcelos JC; Shah PJ
    BJU Int; 2009 Jul; 104(2):216-20. PubMed ID: 19220255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulism toxin: use in disorders of the temporomandibular joint.
    Chang H
    Dent Today; 2005 Dec; 24(12):48, 50-1; quiz 51. PubMed ID: 16396158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.